BRIEF published on 10/21/2024 at 14:06, 17 days 22 hours ago Mainz BioMed publie ses résultats financiers du premier semestre 2024 Résultats Financiers ColoAlert® Mayence Biomed Détection Du Cancer Commentaires De La FDA
BRIEF published on 10/21/2024 at 14:06, 17 days 22 hours ago Mainz BioMed Releases Mid-Year 2024 Financial Results Financial Results FDA Feedback Mainz Biomed ColoAlert® Cancer Detection
PRESS RELEASE published on 10/21/2024 at 14:01, 17 days 22 hours ago Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025 Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
BRIEF published on 10/08/2024 at 14:05, 30 days 22 hours ago Mainz Biomed constate une augmentation de la demande pour le dépistage amélioré ColoAlert Cancer Colorectal Mayence Biomed Test De Dépistage ColoAlert Amélioré Diagnostic GANZIMMUN
BRIEF published on 10/08/2024 at 14:05, 30 days 22 hours ago Mainz Biomed Sees Surge in Demand for Enhanced ColoAlert Screening Mainz Biomed Colorectal Cancer Screening Test Enhanced ColoAlert GANZIMMUN Diagnostics
PRESS RELEASE published on 10/08/2024 at 14:00, 30 days 22 hours ago Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden ColoAlert Mainz Biomed Partners Demand Medizinische Woche
BRIEF published on 10/01/2024 at 14:06, 1 month 6 days ago Le PDG de Mainz Biomed prévoit une croissance substantielle et des essais cliniques auprès de la FDA américaine en 2025 Mayence Biomed Dépistage Du Cancer Colorectal Diagnostic Du Cancer Essais De La FDA Croissance 2025
BRIEF published on 10/01/2024 at 14:06, 1 month 6 days ago Mainz Biomed's CEO Projects Substantial Growth and U.S. FDA Trials in 2025 Cancer Diagnostics Mainz Biomed CRC Screening FDA Trials Growth 2025
PRESS RELEASE published on 10/01/2024 at 14:01, 1 month 6 days ago Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 Mainz Biomed CEO Guido Baechler shares plans for major growth and U.S. FDA trials in 2025, highlighting innovative cancer diagnostics and upcoming clinical developments Growth Cancer Diagnostics CEO Statement Mainz Biomed FDA Trials
BRIEF published on 09/18/2024 at 14:06, 1 month 19 days ago Mainz Biomed annonce Petra Smeltzer Starke comme ambassadrice de la marque DÉTECTION PRÉCOCE Biomedical Ambassadrice De La Marque Dépistage Du Cancer Essai De La FDA
Published on 11/08/2024 at 12:00, 19 minutes ago Fusion Energy Agreement Between RSE and BLUE LASER FUSION (USA)
Published on 11/08/2024 at 10:00, 2 hours 19 minutes ago BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 3 hours 19 minutes ago Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 5 hours 19 minutes ago Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 9 hours 19 minutes ago Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 12:01, 18 minutes ago EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year
Published on 11/08/2024 at 12:01, 18 minutes ago Original-Research: Knaus Tabbert AG (von Montega AG): Kaufen
Published on 11/08/2024 at 11:30, 49 minutes ago Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 1 hour 7 minutes ago Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 1 hour 9 minutes ago Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure
Published on 11/08/2024 at 12:15, 4 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 4 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 4 hours 19 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 17 hours 19 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 17 hours 19 minutes ago ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
